ARYTX
Price
$13.20
Change
+$0.04 (+0.30%)
Updated
Jul 3 closing price
Net Assets
855.62M
MGLRX
Price
$16.74
Change
+$0.02 (+0.12%)
Updated
Jul 3 closing price
Net Assets
2.31B
Interact to see
Advertisement

ARYTX vs MGLRX

Header iconARYTX vs MGLRX Comparison
Open Charts ARYTX vs MGLRXBanner chart's image
American Century Global Real Estate C
Price$13.20
Change+$0.04 (+0.30%)
VolumeN/A
Net Assets855.62M
MFS Global Real Estate R6
Price$16.74
Change+$0.02 (+0.12%)
VolumeN/A
Net Assets2.31B
ARYTX vs MGLRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ARYTX vs. MGLRX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARYTX is a Buy and MGLRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MGLRX has more cash in the bank: 2.31B vs. ARYTX (856M). MGLRX pays higher dividends than ARYTX: MGLRX (2.59) vs ARYTX (1.07). ARYTX was incepted earlier than MGLRX: ARYTX (14 years) vs MGLRX (13 years). ARYTX (2.12) is less costly to investors than MGLRX (0.86). ARYTX is a more actively managed with annual turnover of: 130.00 vs. MGLRX (48.00). MGLRX has a lower initial minimum investment than ARYTX: MGLRX (0) vs ARYTX (2500). ARYTX annual gain was more profitable for investors over the last year : 8.37 vs. MGLRX (5.65). ARYTX return over 5 years is better than : 22.20 vs. MGLRX (14.79).
ARYTXMGLRXARYTX / MGLRX
Total Expense Ratio2.120.85249%
Annual Report Gross Expense Ratio2.120.86247%
Fund Existence14 years13 years-
Gain YTD2.8844.10470%
Front LoadN/AN/A-
Min. Initial Investment25000-
Min. Initial Investment IRAN/AN/A-
Net Assets856M2.31B37%
Annual Yield % from dividends1.072.5942%
Returns for 1 year8.375.65148%
Returns for 3 years12.58-1.47-858%
Returns for 5 years22.2014.79150%
Returns for 10 years39.3435.48111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CVKD12.980.54
+4.34%
Cadrenal Therapeutics Inc
PLTR134.362.24
+1.70%
Palantir Technologies
CRVL102.851.46
+1.44%
CorVel Corp
VERV11.280.07
+0.62%
Verve Therapeutics
BARK0.91-0.03
-2.70%
BARK